4/18/14 Contest update
As traders left for the Good Friday market holiday the Contest median had managed to squeak back into positive territory, closing up .61% YTD (vs. up 3.26% YTD a week ago). However, neither the Nasdaq Biotech Index, down -2.06% YTD (vs. down -4.98% YTD a week ago), nor the Nasdaq Composite Index, down -1.94% YTD (vs. down -4.23% YTD a week ago), made it back to the black.
GENE’s portfolio, now up 26.13% YTD, got hit hard, but remained in the lead by a nanonose. GUERL’s portfolio, up 26.10% YTD, held second place and BIOMAV’s portfolio, up 24.03% YTD, moved up to third place.
At Thursday's close, 25 of the 46 Contest portfolios were in the black, while 29 of the 46 were beating the NBI. The media Contest portfolio stock was down -4.76% YTD.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: none
(All corrections, especially adjustments for splits, greatly appreciated.)
Have a happy Easter & Passover weekend biotechies!
Peace & good health,
Bulba
4/17/14
Rank Name Profit/Loss
1 GENE 26,127
2 GUERL 26,104
3 BIOMAV 24,025
4 JB118 22,891
5 ROCKY 15,389
6 CLARK 12,422
7 RRGE 11,396
8 DOUGH 11,297
9 NIGEL 10,904
10 MCBIO 10,693
Week's Top 5 Gainers
Symbol 4/11 4/17 Wk.%chg.
RGEN 13.65 15.84 16.04%
SKBI 5.08 5.72 12.60%
HZNP 12.02 13.37 11.23%
VVUS 4.84 5.36 10.74%
SRPT 22.18 24.40 10.01%
Week's Worst 5 Losers
Symbol 4/11 4/17 Wk.%chg.
CYTN.SW 2.87 0.180 -93.73%
MRNA 0.98 0.680 -30.61%
TTHI 7.99 5.590 -30.04%
TKMR 18.42 13.050 -29.15%
ONTY 2.97 2.490 -16.16% |
